Milwaukee, WI, July 23, 2016 – ‘A message for immunity: Systemic nanoparticle RNA vaccines mimic infection to fight cancer’, The American Society of Gene & Cell Therapy (ASGCT) publishes an author summary of our publication by Lena M. Kranz and colleagues in the renowned scientific journal Nature.
Winchester, UK, September 13th – ” Systemic nanoparticle RNA vaccines mimic infection to fight cancer”, Lena M. Kranz will speak at the 16th International Conference on Progress in Vaccination Against Cancer (PIVAC-16), Session 5.
Verona, September 7th – TRON Managing Director Prof. Ugur Sahin will speak at the Annual Meeting of the Italian Cancer Society 2016. Ugur Sahin will talk about “RNA based cancer immunotherapy” in the session Cancer immunotherapy (5:00 pm, 2016-09-07).
Vienna, September 01 2016 – TRON Scientific Manager Ugur Sahin will speak at the World Congress on Cancers of the Skin 2016. His talks will cover “Mutanome specific personalized vaccination” (11:30 a.m., 2016-09-01) and “RNA based mutanome specific vaccines – a true personalized therapy” (6:00 p.m., 2016-09-01).
Mainz, July 15 2016 – “Uptake of synthetic naked RNA by DCs allows antigen expression and induction of T-cell responses in mice” – TRON scientist shed further insight into the underlying mechanism of RNA uptake, translation and antigen presentation upon intradermal administration of antigen-encoding RNA.
Mainz, Juli 15 2016 – „Forschungsergebnisse werden zu Therapieverfahren”, Interview mit TRONs wisschenschaftlichem Direktor Prof. Dr. Ugur Sahin im SWR.
Mainz, June 30 2016 – “Tissue-resident regulatory T cells”, Dr. Markus Feuerer from the Helmholtz Young Investigator research group “Immune Tolerance” at the German Cancer Research Center (DKFZ), Heidelberg, Germany is visiting TRON. 5 PM, Lecture Hall Building 205, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany
Mainz, June 02 2016 Breaking News Publication in the renowned Nature journal describes first example of RNA-Lipoplexes as a novel vaccine class that exploit antiviral immune mechanisms for potent cancer immunotherapy. Read more about the media coverage for TRON’s most recent Nature publication here.
Mainz, June 09 2016 – “Abrogation of the immunosuppressive tumor-microenvironment in Hepatocellular Carcinoma by targeting Treg and co-inhibitory pathways”, Dr. Jaap Kwekkeboom & Dr. Dave Sprengers from Erasmus MC-University Medical Centre, Rotterdam are visiting TRON. 5 PM, Lecture Hall Building 708, University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz
Mainz, April 28 2016 – “Exploiting Natural Killer cells for immunotherapy of cancer”, PD Dr. rer. nat. Adelheid Cerwenka from the German Cancer Research Center (DKFZ) is visiting TRON.
Mainz, April 7 2016 – “Regulation of tumor immunity by macrophage and eosinophils”, Prof. Günter Hämmerling from the German Cancer Research Center (DKFZ) is visiting TRON.
Davos, März 16, 2016 – “Eliciting potent T-cells against individual mutant neoantigens – the mutanome as rich target source for individualized cancer vaccination” Vortrag von Dr. Sebastian Kreiter in der Session “Immune Tolerance” auf dem 10. World Immune Regulation Meeting Davos (CH).